Clinical Trial Update: Efficacy of Ultra-micronized Palmitoylethanolamide (Um-PEA) in Geriatric Patients With Chronic Pain [Phase 4]

View source ↗

Summary

Phase 4 trial updating efficacy of ultra-micronized palmitoylethanolamide (Um-PEA) in geriatric patients with chronic pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• ultra-micronized palmitoylethanolamide (palmitoylethanolamide)

Snippet

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Conditions: Chronic Pain | Phase 4 | Status: COMPLETED